IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia

Molecular Genetics and Metabolism

Volumn 105, Issue 2, 2012, Pages 212-220

  Coss, K P ^a   Byrne, J C ^b   Coman, D J ^c   Adamczyk, B ^d   Abrahams, J L ^d   Saldova, R ^d   Brown, A Y ^e   Walsh, O ^f   Hendroff, U ^f   Carolan, C ^g   Rudd, P M ^d   Treacy, E P ^f,h  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^e SOUTHMEAD HOSPITAL   (United Kingdom)

^f National Centre for Inherited Metabolic Disorders Dublin   (Ireland)

^g CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^h TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Biomarkers; Diet liberalization; Galactosaemia; Galactosylation; IgG N glycans; NP HPLC

Indexed keywords

GALACTITOL; GALACTOSE; GLYCAN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CARBOHYDRATE TOLERANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ERYTHROCYTE; FEMALE; GALACTOSE TOLERANCE TEST; GALACTOSEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; URINE LEVEL;

ADULT; BIOMARKERS, PHARMACOLOGICAL; DIET; DRUG TOLERANCE; FEMALE; GALACTOSE; GALACTOSEMIAS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; MALE; POLYSACCHARIDES;

EID: 84856109675     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.10.018     Document Type: Article

References (46)

1. Fridovich-Keil J.L., Walter J.H. Galactosaemia Chapter 72. The Online Metabolic and Molecular Bases of Inherited Disease, OMMBID 2008, McGraw Hill, New York.
2. Waggoner D.D., Buist N.R., Donnell G.N. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J. Inherit. Metab. Dis. 1990, 13(6):802-818.
3. Kaufman F.R., McBride-Chang C., Manis F.R., et al. Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur. J. Pediatr. 1995, 154:S2-S5. (7 Suppl. 2).
4. Cleary M.A., Heptinstall L.E., Wraith J.E., et al. Galactosaemia: relationship of IQ to biochemical control and genotype. J. Inherit. Metab. Dis. 1995, 18(2):151-152.
5. Shield J.P., Wadsworth E.J., MacDonald A., et al. The relationship of genotype to cognitive outcome in galactosaemia. Arch. Dis. Child. 2000, 83(3):248-250.
6. Nelson D. Verbal dyspraxia in children with galactosemia. Eur. J. Pediatr. 1995, 154:S6-S7. (7 Suppl. 2).
7. Schweitzer S., Shin Y., Jakobs C., et al. Long-term outcome in 134 patients with galactosaemia. Eur. J. Pediatr. 1993, 152(1):36-43.
8. Holton J.B. Effects of galactosemia in utero. Eur. J. Pediatr. 1995, 154:S77-S81. (7 Suppl. 2).
9. Bosch A.M. Classical galactosaemia revisited. J. Inherit. Metab. Dis. 2006, 29(4):516-525.
10. Koch T.K., Schmidt K.A., Wagstaff J.E., et al. Neurologic complications in galactosemia. Pediatr. Neurol. 1992, 8(3):217-220.
11. Komrower G.M. Clouds over galactosemia. Lancet 1983, 1(8317):190.
12. Lee P.J., Lilburn M., Wendel U., et al. A woman with untreated galactosaemia. Lancet 2003, 362(9382):446.
13. Panis B., Bakker J.A., Sels J.P., et al. Untreated classical galactosemia patient with mild phenotype. Mol. Genet. Metab. 2006, 89(3):277-279.
14. Coman D.J., Murray D.W., Byrne J.C., et al. Galactosemia, a single gene disorder with epigenetic consequences. Pediatr. Res. 2010, 67:286-292.
15. Bosch A.M., Bakker H.D., Wenniger-Prick L.J., et al. High tolerance for oral galactose in classical galactosaemia: dietary implications. Arch. Dis. Child. 2004, 89(11):1034-1036.
16. Schadewaldt P., Kamalanathan L., Hammen H.W., et al. Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients. Mol. Genet. Metab. 2004, 81(1):31-44.
17. Berry G.T., Nissim I., Lin Z., et al. Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet 1995, 346(8982):1073-1074.
18. Berry G.T., Moate P.J., Reynolds R.A., et al. The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency. Mol. Genet. Metab. 2004, 81(1):22-30.
19. Segal S., Wehrli S., Yager C., et al. Pathways of galactose metabolism by galactosemics: evidence for galactose conversion to hepatic UDPglucose. Mol. Genet. Metab. 2006, 87(2):92-101.
20. Schweitzer-Krantz S. Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia. Eur. J. Pediatr. 2003, 162(Suppl. 1):S50-S53.
21. Hughes J., Ryan S., Lambert D., et al. Outcomes of siblings with classical galactosemia. J. Pediatr. 2009, 154(5):721-726.
22. Hutchesson A.C., Murdoch-Davis C., Green A., et al. Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations. J. Inherit. Metab. Dis. 1999, 22(2):139-148.
23. Apweiler R., Hermjakob H., Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473(1):4-8.
24. Huhn C., Selman M.H., Ruhaak L.R., et al. IgG glycosylation analysis. Proteomics 2009, 9(4):882-913.
25. Dobbie J.A., Holton J.B. A modified method for the estimation of galactose-1-phosphate. Ann. Clin. Biochem. 1986, 23(Pt 3):325-328.
26. Murphy D., Pennock C.A. Gas chromatographic measurement of blood and urine glucose and other monosaccharides. Clin. Chim. Acta 1972, 42(1):67-75.
27. Murphy M., McHugh B., Tighe O., et al. Genetic basis of transferase-deficient galactosaemia in Ireland and the population history of the Irish Travellers. Eur. J. Hum. Genet. 1999, 7(5):549-554.
28. Royle L., Campbell M.P., Radcliffe C.M., et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 2008, 376(1):1-12.
29. Bigge J.C., Patel T.P., Bruce J.A., et al. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 1995, 230(2):229-238.
30. Kuster B., Wheeler S.F., Hunter A.P., et al. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal. Biochem. 1997, 250(1):82-101.
31. Royle L., Radcliffe C.M., Dwek R.A., et al. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol. Biol. 2006, 347:125-143.
32. M. Pucic, A. Knezevic, J. Vidic, et al., High throughput isolation and glycosylation analysis of IgG - variability and heritability of the IgG glycome in three isolated human populations, Mol. Cell Proteomics 10 (10) (2011) M111 010090.
33. Youings A., Chang S.C., Dwek R.A., et al. Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem. J. 1996, 314(Pt 2):621-630.
34. Sarrats A., Saldova R., Comet J., et al. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma. OMICS 2010, 14(4):465-474.
35. Charlwood J., Clayton P., Keir G., et al. Defective galactosylation of serum transferrin in galactosemia. Glycobiology 1998, 8(4):351-357.
36. Butler M., Quelhas D., Critchley A.J., et al. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology 2003, 13(9):601-622.
37. Quintana E., Navarro-Sastre A., Hernandez-Perez J.M., et al. Screening for congenital disorders of glycosylation (CDG): transferrin HPLC versus isoelectric focusing (IEF). Clin. Biochem. 2009, 42(4-5):408-415.
38. Stibler H., von Dobeln U., Kristiansson B., et al. Carbohydrate-deficient transferrin in galactosaemia. Acta Paediatr. 1997, 86(12):1377-1378.
39. Prestoz L.L., Couto A.S., Shin Y.S., et al. Altered follicle stimulating hormone isoforms in female galactosaemia patients. Eur. J. Pediatr. 1997, 156(2):116-120.
40. Jaeken J., Kint J., Spaapen L. Serum lysosomal enzyme abnormalities in galactosaemia. Lancet 1992, 340(8833):1472-1473.
41. Slepak T.I., Tang M., Slepak V.Z., et al. Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model. Mol. Genet. Metab. 2007, 92(1-2):78-87.
42. Sturiale L., Barone R., Fiumara A., et al. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology 2005, 15(12):1268-1276.
43. Yamada E., Tsukamoto Y., Sasaki R., et al. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj. J. 1997, 14(3):401-405.
44. Parekh R., Roitt I., Isenberg D., et al. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 1988, 167(5):1731-1736.
45. Halder R.C., Jahng A., Maricic I., et al. Mini review: immune response to myelin-derived sulfatide and CNS-demyelination. Neurochem. Res. 2007, 32(2):257-262.
46. Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 2008, 31(7):361-370.